Press Release FOR IMMEDIATE RELEASE Contact: Patricia Vaccarino Sarah Wakefield Managing Partner Senior Director of Marketing Communications Xanthus Communications Iverson Genetics Diagnostics, Inc. +1-206-979-3380 +1-206-946-6006
[email protected] [email protected] Iverson Genetic Diagnostics Announces Changes to its Management Team and Board of Directors: Yelena Shevelenko named as interim CEO and Jeffrey O. Nyweide named as the company’s new CFO Founder and CEO, Dean Sproles, is on leave Seattle, WA April 7, 2014 — Today it was announced that changes have been made to the management team of Iverson Genetic Diagnostics, Inc. CEO, President, and Chairman of the Board Dean Sproles is on leave. Dean will be attending to personal matters while on leave, but has offered to be available as needed to support the Interim Management Team. Respect for his privacy does not allow us to further comment on the details of his leave. Yelena Shevelenko has been named as interim CEO and Jeffrey O. Nyweide has been named as the interim CFO. Harvey Schiller, Ph.D., who has been appointed as Chairman of the Board of Directors, made the announcement. Dr. Schiller stated, “As founder and CEO of Iverson Genetic Diagnostics, Dean Sproles has made a significant contribution to the company, and while he will no longer be involved in the company’s day-to-day operations, he will still be available in an advisory capacity, and he will continue to serve as a member of the Board of Directors.” New interim CEO Yelena Shevelenko brings over 20 years of experience in executive management and leadership positions to Iverson Genetic Diagnostics.